McCormick J E, McElhinney R S
Laboratories of the Medical Research Council of Ireland, Trinity College, Dublin.
Anticancer Drug Des. 1986 Apr;1(2):111-23.
The biological study of molecular combination of anti-tumour drugs remains unexplored. Some drugs prepared earlier, seco-nucleosides with 5-fluorouracil as base and incorporating a N-(2-chloroethyl)-N-nitrosourea (CNU) residue in the linear 'sugar' moiety, have now been obtained much more readily by using aryl N-nitrosocarbamates. These include the more reactive S-oxide of the original combination, B 3839. The structure of a compound with the CNU in the 'alcohol' arm of the seco-nucleoside has been clarified. Isomeric combinations having hydroxyl groups in either the 'alcohol' or the 'aldehyde' arm, with different hydrolysis rates, have been synthesized. Results of anti-tumour testing are reported in the proceeding paper.
抗肿瘤药物分子组合的生物学研究仍未得到充分探索。一些早期制备的药物,即以5-氟尿嘧啶为碱基、在线性“糖”部分引入N-(2-氯乙基)-N-亚硝基脲(CNU)残基的裂环核苷,现在通过使用芳基N-亚硝基氨基甲酸酯能更容易地获得。这些药物包括原始组合中活性更高的S-氧化物B 3839。一种在裂环核苷的“醇”臂中含有CNU的化合物的结构已得到阐明。已经合成了在“醇”臂或“醛”臂中带有羟基、水解速率不同的异构体组合。抗肿瘤测试结果在后续论文中报道。